Literature DB >> 22105155

Proteotoxic stress of cancer: implication of the heat-shock response in oncogenesis.

Chengkai Dai1, Siyuan Dai, Junyue Cao.   

Abstract

Organisms frequently encounter a wide variety of proteotoxic stressors. The heat-shock response, an ancient cytoprotective mechanism, has evolved to augment organismal survival and longevity in the face of proteotoxic stress from without and within. These broadly recognized beneficial effects, ironically, contrast sharply with its emerging role as a culprit in the pathogenesis of cancers. Here, we present an overview of the normal biology of the heat-shock response and highlight its implications in oncogenic processes, including the proteotoxic stress phenotype of cancer; the function of this stress response in helping cancer survive and adapt to proteotoxic stress; and perturbation of proteome homeostasis in cancer as a potential therapeutic avenue.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22105155      PMCID: PMC3431153          DOI: 10.1002/jcp.24017

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  77 in total

1.  Heat shock factor 1 contains two functional domains that mediate transcriptional repression of the c-fos and c-fms genes.

Authors:  Yue Xie; Rong Zhong; Changmin Chen; Stuart K Calderwood
Journal:  J Biol Chem       Date:  2002-12-04       Impact factor: 5.157

2.  Phosphorylation of serine 303 is a prerequisite for the stress-inducible SUMO modification of heat shock factor 1.

Authors:  Ville Hietakangas; Johanna K Ahlskog; Annika M Jakobsson; Maria Hellesuo; Niko M Sahlberg; Carina I Holmberg; Andrey Mikhailov; Jorma J Palvimo; Lila Pirkkala; Lea Sistonen
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

3.  Redox regulation of mammalian heat shock factor 1 is essential for Hsp gene activation and protection from stress.

Authors:  Sang-Gun Ahn; Dennis J Thiele
Journal:  Genes Dev       Date:  2003-02-15       Impact factor: 11.361

Review 4.  Rationale for the treatment of solid tumors with the proteasome inhibitor bortezomib.

Authors:  James C Cusack
Journal:  Cancer Treat Rev       Date:  2003-05       Impact factor: 12.111

5.  The role of heat shock transcription factor 1 in the genome-wide regulation of the mammalian heat shock response.

Authors:  Nathan D Trinklein; John I Murray; Sara J Hartman; David Botstein; Richard M Myers
Journal:  Mol Biol Cell       Date:  2003-12-10       Impact factor: 4.138

6.  Impaired IgG production in mice deficient for heat shock transcription factor 1.

Authors:  Sachiye Inouye; Hanae Izu; Eiichi Takaki; Harumi Suzuki; Mutsunori Shirai; Yoshifumi Yokota; Hitoshi Ichikawa; Mitsuaki Fujimoto; Akira Nakai
Journal:  J Biol Chem       Date:  2004-06-29       Impact factor: 5.157

7.  Heat shock transcription factor 2 is not essential for embryonic development, fertility, or adult cognitive and psychomotor function in mice.

Authors:  D Randy McMillan; Elisabeth Christians; Michael Forster; XianZhong Xiao; Patrice Connell; Jean-Christophe Plumier; XiaoXia Zuo; James Richardson; Sylvia Morgan; Ivor J Benjamin
Journal:  Mol Cell Biol       Date:  2002-11       Impact factor: 4.272

8.  Transcriptional activity and DNA binding of heat shock factor-1 involve phosphorylation on threonine 142 by CK2.

Authors:  Fabrice Soncin; Xinfeng Zhang; Boyang Chu; Xiaozhe Wang; Alexzander Asea; Mary Ann Stevenson; David B Sacks; Stuart K Calderwood
Journal:  Biochem Biophys Res Commun       Date:  2003-04-04       Impact factor: 3.575

Review 9.  Overview: translating Hsp90 biology into Hsp90 drugs.

Authors:  Paul Workman
Journal:  Curr Cancer Drug Targets       Date:  2003-10       Impact factor: 3.428

10.  Genome-wide analysis of the biology of stress responses through heat shock transcription factor.

Authors:  Ji-Sook Hahn; Zhanzhi Hu; Dennis J Thiele; Vishwanath R Iyer
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

View more
  41 in total

1.  A pyrrole-based natural small molecule mitigates HSP90 expression in MDA-MB-231 cells and inhibits tumor angiogenesis in mice by inactivating HSF-1.

Authors:  K C Rashmi; H S Atreya; M Harsha Raj; Bharathi P Salimath; H S Aparna
Journal:  Cell Stress Chaperones       Date:  2017-07-17       Impact factor: 3.667

Review 2.  Proteolytic control of genome integrity at the replication fork.

Authors:  Julie Rageul; Alexandra S Weinheimer; Jennifer J Park; Hyungjin Kim
Journal:  DNA Repair (Amst)       Date:  2019-07-10

Review 3.  Tumor cell survival pathways activated by photodynamic therapy: a molecular basis for pharmacological inhibition strategies.

Authors:  Mans Broekgaarden; Ruud Weijer; Thomas M van Gulik; Michael R Hamblin; Michal Heger
Journal:  Cancer Metastasis Rev       Date:  2015-12       Impact factor: 9.264

Review 4.  The heat-shock, or HSF1-mediated proteotoxic stress, response in cancer: from proteomic stability to oncogenesis.

Authors:  Chengkai Dai
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-01-19       Impact factor: 6.237

5.  Development of Phenyl Cyclohexylcarboxamides as a Novel Class of Hsp90 C-terminal Inhibitors.

Authors:  Gaurav Garg; Leah K Forsberg; Huiping Zhao; Brian S J Blagg
Journal:  Chemistry       Date:  2017-11-03       Impact factor: 5.236

6.  Cellular senescence and protein degradation: breaking down cancer.

Authors:  Xavier Deschênes-Simard; Frédéric Lessard; Marie-France Gaumont-Leclerc; Nabeel Bardeesy; Gerardo Ferbeyre
Journal:  Cell Cycle       Date:  2014-05-27       Impact factor: 4.534

7.  The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges.

Authors:  G R Tundo; D Sbardella; A M Santoro; A Coletta; F Oddone; G Grasso; D Milardi; P M Lacal; S Marini; R Purrello; G Graziani; M Coletta
Journal:  Pharmacol Ther       Date:  2020-05-19       Impact factor: 12.310

Review 8.  Targeting tumour-supportive cellular machineries in anticancer drug development.

Authors:  Matthias Dobbelstein; Ute Moll
Journal:  Nat Rev Drug Discov       Date:  2014-03       Impact factor: 84.694

9.  Cowden syndrome-related mutations in PTEN associate with enhanced proteasome activity.

Authors:  Xin He; Nicholas Arrotta; Deepa Radhakrishnan; Yu Wang; Todd Romigh; Charis Eng
Journal:  Cancer Res       Date:  2013-03-08       Impact factor: 12.701

Review 10.  HSF1: Guardian of Proteostasis in Cancer.

Authors:  Chengkai Dai; Stephen Byers Sampson
Journal:  Trends Cell Biol       Date:  2015-11-18       Impact factor: 20.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.